1. Home
  2. BBAI vs ARQT Comparison

BBAI vs ARQT Comparison

Compare BBAI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BigBear.ai Inc.

BBAI

BigBear.ai Inc.

HOLD

Current Price

$5.87

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$29.64

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBAI
ARQT
Founded
2020
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BBAI
ARQT
Price
$5.87
$29.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$7.00
$24.83
AVG Volume (30 Days)
91.7M
2.6M
Earning Date
11-10-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$144,199,000.00
$317,929,000.00
Revenue This Year
N/A
$85.27
Revenue Next Year
$13.83
$30.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
129.21
52 Week Low
$2.12
$11.13
52 Week High
$10.36
$31.27

Technical Indicators

Market Signals
Indicator
BBAI
ARQT
Relative Strength Index (RSI) 45.68 66.51
Support Level $5.03 $27.08
Resistance Level $6.44 $31.27
Average True Range (ATR) 0.60 1.56
MACD 0.04 0.19
Stochastic Oscillator 34.60 81.91

Price Performance

Historical Comparison
BBAI
ARQT

About BBAI BigBear.ai Inc.

BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: